Ledger.Open graph →
SEC Form D · Amendment · filed January 8, 2015

Reset Therapeutics, Inc

Offering
$6.5M
Sold
$5.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SOUTH SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Steve B. Kay · South San Francisco, CADirectorPeter B. Schultz · South San Francisco, CADirectorShuichi B. Kurosaki · South San Francisco, CAExecRoss Bersot · San Francisco, CAExec · DirectorPaul B. Humphries · South San Francisco, CAExecFrederick B. Craves · San Francisco, CADirectorGary Langendoen · Pasadena, CADirectorJason A. Gilbert · Dallas, TXExecMichael P. Hite · Seattle, WAExecBen H. Weinberg · Minneapolis, MNExec · DirectorJohn D. Hoekman · Seattle, WAExec · DirectorParker A. Hallam · Dallas, TXDirectorStewart D. Parker · Seattle, WADirectorQuentin Blackford · Carlsbad, CAExec · DirectorMatthew Arnold · Lafayette, CODirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗